Device Trial Radar · NCT04734535
Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery
Last checked: Nov 19, 2026Latest source record: Apr 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Mar 8, 2021
Primary completion
Feb 5, 2024
Study completion Feb 5, 2024
Sponsor
- Lead sponsor
- Dilon Technologies Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Syneos Health
- First posted
- Feb 2, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical investigation in open, elective, spine surgery is to collect data to support the removal of the neurosurgical exclusion from the currently approved indication for the use of HEMOBLAST™ Bellows. This study is primarily designed to assess safety of the device for use in spine surgery, although efficacy information will also be captured and reported.
Conditions
- Surgical Bleeding
Interventions
HEMOBLAST™ BellowsDevice
Intraoperative bleeding during epidural spine surgery will be treated with HEMOBLAST™ Bellows
absorbable gelatin sponge with thrombinDevice
Intraoperative bleeding during epidural spine surgery will be treated with absorbable gelatin sponge with thrombin
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Unanticipated Adverse Device Effect (UADE)Time frame: 3 months follow-up
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
University of Southern California
Los Angeles, California
Indiana Spine Group
Carmel, Indiana
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.